<DOC>
	<DOCNO>NCT00192335</DOCNO>
	<brief_summary>- Primary objective demonstrate equivalent immunogeniticity CAIV-T FluMist - Secondary objective study assess safety tolerability CAIV-T compare FluMist</brief_summary>
	<brief_title>Trial Demonstrate Equivalent Immunogenicity CAIV-T FLUMIST Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Age 5 49 year ( yet reach 50th birthday ) ; In general good health ; Individual parent/guardian available telephone ; Ability participant parent/guardian understand comply requirement protocol ; Written inform consent HIPAA authorization obtain participant 's parent legal guardian write informed consent HIPAA authorization obtain participant . History hypersensitivity component FluMist CAIVT , include egg egg product ; History hypersensitivity gentamicin ; Any know immunosuppressive condition immune deficiency disease ( include HIV infection ) , ongoing receipt immunosuppressive therapy ; Household contact immunocompromised ( participant also avoid close contact immunocompromised individual least 21 day ) ; History chronic underlie medical condition chronic disorder cardiovascular pulmonary system , chronic metabolic disease ( include diabetes ) , renal dysfunction , hemoglobinopathy ; History GuillainBarré syndrome ; History asthma reactive airway disease ; For child age 5 8 year , receipt prior influenza vaccination ; Acute febrile ( &gt; 100.0°F oral ) and/or respiratory illness within 72 hour prior enrollment ; For participant age 18 , use aspirin aspirin contain product 30 day prior enrollment anticipate use study ; Administration live vaccine within 30 day prior enrollment receipt another live vaccine expect within 30 day vaccination study ; Administration inactivate vaccine within two week prior enrollment receipt another inactivate vaccine expect within two week vaccination study ; Pregnancy , biologically capable woman ( e.g. , menses within last year ) , willing agree acceptable birth control 90 day enrol study ( biologically capable , urine pregnancy test must perform day vaccination negative result ) ; Breastfeeding lactate woman ; Participation another investigational trial administration investigational drug within 30 day prior enrollment study ; Receipt blood product within 90 day prior vaccination expect receipt within study duration ; Employees research center , individual involve conduct study , family member individual ; Any condition opinion investigator would interfere interpretation evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>